Found: 19
Select item for more details and to access through your institution.
Editorial: direct‐acting antivirals significantly improve quality of life in patients with hepatitis C virus infection—Author's reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 537, doi. 10.1111/apt.14481
- By:
- Publication type:
- Article
Editorial: tofacitinib and biologics for moderate‐to‐severe ulcerative colitis—what is best in class? Authors’ reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 540, doi. 10.1111/apt.14486
- By:
- Publication type:
- Article
Editorial: tofacitinib and biologics for moderate‐to‐severe ulcerative colitis—what is best in class?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Editorial: getting bullish about portal hypertension—chronic treatment with oral taurine? Author's reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 534, doi. 10.1111/apt.14477
- By:
- Publication type:
- Article
Letter: more studies are needed to elucidate the impact of HBV/HCV coinfection on cirrhosis and its consequences—Authors’ reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Serum pepsinogen 1 and anti‐<italic>Helicobacter pylori</italic> IgG antibodies as predictors of gastric cancer risk in Finnish males.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 494, doi. 10.1111/apt.14471
- By:
- Publication type:
- Article
Letter: addition of azathioprine to infliximab maintenance therapy in patients with anti‐drug antibodies and subclinical inflammation.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Editorial: direct‐acting antivirals significantly improve quality of life in patients with hepatitis C virus infection.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross‐sectional study using transient elastography.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 504, doi. 10.1111/apt.14463
- By:
- Publication type:
- Article
Editorial: vedolizumab as a treatment and cause of extra‐intestinal manifestations of inflammatory bowel disease.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Infliximab trough concentrations during maintenance therapy are associated with endoscopic and histologic healing in ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 478, doi. 10.1111/apt.14458
- By:
- Publication type:
- Article
Systematic review: ileoanal pouch microbiota in health and disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 466, doi. 10.1111/apt.14454
- By:
- Publication type:
- Article
Systematic review with network meta‐analysis: comparative assessment of tofacitinib and biological therapies for moderate‐to‐severe ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 454, doi. 10.1111/apt.14449
- By:
- Publication type:
- Article
Letter: more studies are needed to elucidate the impact of HBV/HCV coinfection on cirrhosis and its consequences.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 451, doi. 10.1111/apt.14298
- Publication type:
- Article
Safety and efficacy of sofosbuvir‐based treatment of acute hepatitis C in end‐stage renal disease patients undergoing haemodialysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 526, doi. 10.1111/apt.14429
- By:
- Publication type:
- Article
Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 485, doi. 10.1111/apt.14419
- By:
- Publication type:
- Article
Editorial: getting bullish about portal hypertension—chronic treatment with oral taurine?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 516, doi. 10.1111/apt.14427
- By:
- Publication type:
- Article